HomeMarketsSharesDoximity, Inc.

Trade Doximity, Inc. - DOCS CFD

Market is not available at the momentMarket information is presented
as of 2026-10-09T19:47:50+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.11
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022179 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02218%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000043 %
(-$0.01)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00004%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close29.33
Open29.07
1-Year Change-60.37%
Day's Range29.07 - 30.31

Trade Doximity, Inc. - DOCS

Keep up-to-date with the Doximity share price using Capital.com’s live chart.

Doximity Inc. (DOCS) is an online social networking platform dedicated to medical professionals in the US. Headquartered in San Francisco and described as the ‘professional medical network for clinicians’ or the ‘LinkedIn for doctors’, Doximity’s platform provides users with a range of features designed to improve communication between doctors, patients and other medical practitioners.

Doximity went public in June 2021, listing its shares on the New York Stock Exchange (NYSE) under the ticker symbol DOCS. 

Join Capital.com today to stay on top of the latest changes in the Doximity Inc. (DOCS) stock price.

The platform, which launched in 2010, was co-founded by Nate Gross, Shari Buck and Jeff Tangney, with a vision to make medical communication effortless – helping clinicians to be more productive, thereby enhancing the patient experience. By 2014, 40% of US physicians had become Doximity members. In 2017, membership had grown to 1 million, accounting for more than 70% of registered physicians in the US.

Similar to other social networking platforms, Doximity is packed with features. Alongside a news feed which provides tailored content to users based on their specialisation or interests, Doximity’s comprehensive directory of medical practitioners allows users to search for other users – be it to discuss a patient referral or catch up about their weekend. Other features include a secure faxing tool, as well as Doximity Dialer, giving members the capability to make telephone or video calls with patients, while ensuring the confidentiality of the user’s personal contact details. 

With Capital.com’s comprehensive DOCS share price chart, you can quickly view the company's current and historic share prices.

On 28 May 2021, the company announced its intention to launch an initial public offering (IPO), filing S-1 with the US Securities and Exchange Commission (SEC). The IPO took place on 23 June 2021, with Doximity selling 23.3 million shares priced at $26 a piece. It raised nearly $600m.

On 24 June, the stock started the trading session on the NYSE at $41.17 a share, before rapidly rising to an intraday high of $53.89 a share. The share price closed the trading day at $53, up 31%.

You can trace all the ups and downs of the Doximity stock quote live and go long or short on the company’s shares with contracts for difference (CFDs) using Capital.com’s proprietary trading platform.

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready